Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Wave Life Sciences (WVE)

Wave Life Sciences Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:WVE
DateTimeSourceHeadlineSymbolCompany
25/06/202412:30GlobeNewswire Inc.Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington’s DiseaseNASDAQ:WVEWave Life Sciences Ltd
12/06/202413:30GlobeNewswire Inc.Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA EditingNASDAQ:WVEWave Life Sciences Ltd
30/05/202413:30GlobeNewswire Inc.Wave Life Sciences to Present at 2024 Jefferies Global Healthcare ConferenceNASDAQ:WVEWave Life Sciences Ltd
10/05/202412:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:WVEWave Life Sciences Ltd
09/05/202412:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WVEWave Life Sciences Ltd
09/05/202412:30GlobeNewswire Inc.Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:WVEWave Life Sciences Ltd
09/05/202412:00GlobeNewswire Inc.Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific OfficerNASDAQ:WVEWave Life Sciences Ltd
07/05/202413:30GlobeNewswire Inc.Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:WVEWave Life Sciences Ltd
02/05/202413:30GlobeNewswire Inc.Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024NASDAQ:WVEWave Life Sciences Ltd
30/04/202413:30GlobeNewswire Inc.Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)NASDAQ:WVEWave Life Sciences Ltd
23/04/202413:30GlobeNewswire Inc.Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA EditingNASDAQ:WVEWave Life Sciences Ltd
27/03/202412:30GlobeNewswire Inc.Wave Life Sciences to Present at Upcoming Investor ConferencesNASDAQ:WVEWave Life Sciences Ltd
06/03/202412:55Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:WVEWave Life Sciences Ltd
06/03/202412:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WVEWave Life Sciences Ltd
06/03/202412:30GlobeNewswire Inc.Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:WVEWave Life Sciences Ltd
28/02/202413:30GlobeNewswire Inc.Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024NASDAQ:WVEWave Life Sciences Ltd
27/02/202413:30GlobeNewswire Inc.Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular DystrophyNASDAQ:WVEWave Life Sciences Ltd
12/02/202421:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:WVEWave Life Sciences Ltd
08/02/202400:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WVEWave Life Sciences Ltd
08/02/202400:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WVEWave Life Sciences Ltd
08/02/202400:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WVEWave Life Sciences Ltd
08/02/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WVEWave Life Sciences Ltd
08/01/202413:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WVEWave Life Sciences Ltd
08/01/202413:00GlobeNewswire Inc.Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 MilestonesNASDAQ:WVEWave Life Sciences Ltd
04/01/202421:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WVEWave Life Sciences Ltd
03/01/202413:30GlobeNewswire Inc.Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:WVEWave Life Sciences Ltd
15/12/202313:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WVEWave Life Sciences Ltd
15/12/202313:30GlobeNewswire Inc.Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenne Muscular DystrophyNASDAQ:WVEWave Life Sciences Ltd
08/12/202311:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:WVEWave Life Sciences Ltd
08/12/202302:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WVEWave Life Sciences Ltd
 Showing the most relevant articles for your search:NASDAQ:WVE